TrovaGene leads healthcare gainers; Merrimack Pharmaceuticals and Syros Pharmaceuticals among losers

Apr. 05, 2019 11:01 AM ETCRDF, NVNO, ZYNE, CRBP, EVGN, LIVN, SYRS, AQB, OTLK, MACKBy: Akanksha Bakshi, SA News Editor2 Comments
  • Gainers: TrovaGene (NASDAQ:TROV) +16%. Hancock Jaffe Laboratories (NASDAQ:HJLI) +11%. Zynerba Pharmaceuticals (NASDAQ:ZYNE+9%. Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) +8%. Evogene (NASDAQ:EVGN) +6%.
  • Losers: LivaNova (NASDAQ:LIVN) -26%. Syros Pharmaceuticals (NASDAQ:SYRS) -23%. AquaBounty Technologies (NASDAQ:AQB) -20%. Outlook Therapeutics (NASDAQ:OTLK) -11%. Merrimack Pharmaceuticals (NASDAQ:MACK) -11%.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.